Peter J. Harvison

917 total citations
30 papers, 811 citations indexed

About

Peter J. Harvison is a scholar working on Pharmacology, Plant Science and Molecular Biology. According to data from OpenAlex, Peter J. Harvison has authored 30 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 9 papers in Plant Science and 7 papers in Molecular Biology. Recurrent topics in Peter J. Harvison's work include Drug-Induced Hepatotoxicity and Protection (14 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Pesticide Exposure and Toxicity (9 papers). Peter J. Harvison is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (14 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Pesticide Exposure and Toxicity (9 papers). Peter J. Harvison collaborates with scholars based in United States, Sweden and Ghana. Peter J. Harvison's co-authors include Mats Rundgren, Peter Moldéus, Emanuele Albano, Sidney D. Nelson, Sidney D. Nelson, Sidney D. Nelson, F. Peter Guengerich, Mohamed S. Rashed, Alexander K. Nyarko and Ruy Tchao and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Biochemical Pharmacology.

In The Last Decade

Peter J. Harvison

30 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter J. Harvison United States 15 460 197 174 134 104 30 811
Daniel Fau France 19 519 1.1× 457 2.3× 159 0.9× 135 1.0× 86 0.8× 31 1.3k
George J. Traiger United States 18 407 0.9× 166 0.8× 127 0.7× 120 0.9× 54 0.5× 34 816
John W. Cameron United States 3 532 1.2× 251 1.3× 220 1.3× 73 0.5× 39 0.4× 3 863
Marlene E. Kyle United States 14 311 0.7× 323 1.6× 126 0.7× 136 1.0× 77 0.7× 17 931
Sidney D. Nelson United States 9 429 0.9× 176 0.9× 195 1.1× 47 0.4× 66 0.6× 9 664
Mi‐Sook Dong South Korea 18 367 0.8× 386 2.0× 143 0.8× 83 0.6× 60 0.6× 40 937
Jouko Uusitalo Finland 18 547 1.2× 350 1.8× 243 1.4× 134 1.0× 29 0.3× 23 1.1k
J.A. Beamand United Kingdom 20 532 1.2× 566 2.9× 225 1.3× 112 0.8× 47 0.5× 34 1.4k
Yasuhiro Masubuchi Japan 17 783 1.7× 329 1.7× 344 2.0× 43 0.3× 55 0.5× 39 1.2k
John R. Soglia United States 16 461 1.0× 386 2.0× 175 1.0× 38 0.3× 103 1.0× 20 956

Countries citing papers authored by Peter J. Harvison

Since Specialization
Citations

This map shows the geographic impact of Peter J. Harvison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Harvison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Harvison more than expected).

Fields of papers citing papers by Peter J. Harvison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Harvison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Harvison. The network helps show where Peter J. Harvison may publish in the future.

Co-authorship network of co-authors of Peter J. Harvison

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Harvison. A scholar is included among the top collaborators of Peter J. Harvison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Harvison. Peter J. Harvison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zauhar, Randy J., et al.. (2015). Cytotoxicity of thiazolidinedione-, oxazolidinedione- and pyrrolidinedione-ring containing compounds in HepG2 cells. Toxicology in Vitro. 29(7). 1887–1896. 7 indexed citations
2.
Rushmore, Thomas H., et al.. (2011). Cytotoxicity of 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT) and analogues in wild type and CYP3A4 stably transfected HepG2 cells. Toxicology in Vitro. 25(8). 2113–2119. 10 indexed citations
3.
Tchao, Ruy, et al.. (2008). Role of biotransformation in 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity in Fischer 344 rats. Toxicology. 250(2-3). 100–108. 9 indexed citations
7.
Cui, Donghui & Peter J. Harvison. (2000). Determination of the site of glucuronidation in anN-(3,5-dichlorophenyl)succinimide metabolite by electrospray ionization tandem mass spectrometry following derivatization to picolinyl esters. Rapid Communications in Mass Spectrometry. 14(21). 1985–1990. 11 indexed citations
8.
Kellner-Weibel, Ginny, et al.. (1999). Comparative Disposition of the Nephrotoxicant N-(3,5-Dichlorophenyl)Succinimide and the Non-Nephrotoxicant N-(3,5-Difluorophenyl)Succinimide in Fischer 344 Rats. Drug Metabolism and Disposition. 27(6). 674–680. 5 indexed citations
9.
10.
Nyarko, Alexander K., Ginny Kellner-Weibel, & Peter J. Harvison. (1997). Cytochrome P450-Mediated Metabolism and Nephrotoxicity of N-(3,5-Dichlorophenyl)succinimide in Fischer 344 Rats. Toxicological Sciences. 37(2). 117–124. 13 indexed citations
11.
Griffin, Robert, et al.. (1996). In vitrometabolism of the nephrotoxicantN-(3,5-dichlorophenyl)succinimide in the Fischer 344 rat and New Zealand white rabbit. Xenobiotica. 26(4). 369–380. 10 indexed citations
12.
Nyarko, Alexander K. & Peter J. Harvison. (1995). Metabolism of the nephrotoxicant N-(3,5-dichlorophenyl)succinimide by isolated rat hepatocytes.. Drug Metabolism and Disposition. 23(1). 107–112. 25 indexed citations
13.
Harvison, Peter J., et al.. (1992). Nephrotoxic potential of N-(3,5-dichloro-4-hydroxyphenyl)succinimide and N-(3,5-dichloro-4-hydroxyphenyl)succinamic acid in Fischer-344 rats. Toxicology Letters. 60(2). 221–226. 14 indexed citations
14.
Harvison, Peter J. & Thomas I. Kalman. (1992). Synthesis and biological activity of novel folic acid analogs: pteroyl-S-alkylhomocysteine sulfoximines. Journal of Medicinal Chemistry. 35(7). 1227–1233. 14 indexed citations
15.
Cannon, John R., Peter J. Harvison, & Glenn F. Rush. (1991). The effects of fructose on adenosine triphosphate depletion following mitochondrial dysfunction and lethal cell injury in isolated rat hepatocytes. Toxicology and Applied Pharmacology. 108(3). 407–416. 30 indexed citations
16.
Harvison, Peter J., F. Peter Guengerich, Mohamed S. Rashed, & Sidney D. Nelson. (1988). Cytochrome P-450 isozyme selectivity in the oxidation of acetaminophen. Chemical Research in Toxicology. 1(1). 47–52. 88 indexed citations
17.
Harvison, Peter J., et al.. (1988). Acetaminophen and analogs as cosubstrates and inhibitors of prostaglandin H synthase. Chemico-Biological Interactions. 64(3). 251–266. 43 indexed citations
18.
Rundgren, Mats, David J. Porubek, Peter J. Harvison, et al.. (1988). Comparative cytotoxic effects of N-acetyl-p-benzoquinone imine and two dimethylated analogues.. Molecular Pharmacology. 34(4). 566–572. 32 indexed citations
20.
Albano, Emanuele, Mats Rundgren, Peter J. Harvison, Sidney D. Nelson, & Peter Moldéus. (1985). Mechanisms of N-acetyl-p-benzoquinone imine cytotoxicity.. Molecular Pharmacology. 28(3). 306–311. 279 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026